We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.06%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCEF icon
2151
Invesco CEF Income Composite ETF
PCEF
$811M
$815K ﹤0.01%
34,417
+1,005
+3% +$23.7K
EVI icon
2152
EVI Industries
EVI
$180M
$812K ﹤0.01%
+30,000
New +$695K
UPBD icon
2153
Upbound Group
UPBD
$1.14B
$812K ﹤0.01%
+69,260
New +$783K
USCR
2154
DELISTED
U S Concrete, Inc.
USCR
$809K ﹤0.01%
10,304
+1,429
+16% +$97.1K
IBDL
2155
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
$807K ﹤0.01%
31,645
+263
+0.8% +$6.7K
BRSL
2156
Brightstar Lottery PLC
BRSL
$2.03B
$806K ﹤0.01%
44,064
-6,139
-12% -$126K
TTD icon
2157
Trade Desk
TTD
$8.31B
$806K ﹤0.01%
160,820
+93,580
+139% +$428K
SFL icon
2158
SFL Corp
SFL
$1.61B
$803K ﹤0.01%
59,025
+10,756
+22% +$147K
RH icon
2159
RH
RH
$3.56B
$801K ﹤0.01%
12,415
-1,799
-13% -$95.2K
BBH icon
2160
VanEck Biotech ETF
BBH
$410M
$798K ﹤0.01%
6,355
+400
+7% +$48.2K
SIGI icon
2161
Selective Insurance
SIGI
$5.77B
$798K ﹤0.01%
15,951
-780
-5% -$38.5K
DY icon
2162
Dycom Industries
DY
$12B
$789K ﹤0.01%
8,812
-7,631
-46% -$740K
AVA icon
2163
Avista
AVA
$3.22B
$788K ﹤0.01%
18,552
+219
+1% +$9.14K
UNB icon
2164
Union Bankshares
UNB
$109M
$788K ﹤0.01%
16,579
-1,290
-7% -$55.3K
OSB
2165
DELISTED
Norbord Inc.
OSB
$786K ﹤0.01%
25,247
+11,863
+89% +$351K
EES icon
2166
WisdomTree US SmallCap Earnings Fund
EES
$726M
$784K ﹤0.01%
23,872
+3,436
+17% +$111K
WIX icon
2167
WIX.com
WIX
$2.55B
$784K ﹤0.01%
11,264
-3,442
-23% -$257K
FAD icon
2168
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$586M
$783K ﹤0.01%
13,413
CG icon
2169
Carlyle Group
CG
$17.6B
$782K ﹤0.01%
39,599
+3,930
+11% +$69.3K
HPI
2170
John Hancock Preferred Income Fund
HPI
$431M
$781K ﹤0.01%
35,721
+6,310
+21% +$138K
GGM
2171
DELISTED
GUGGENHEIM CREDIT ALLOCATION FUND
GGM
$780K ﹤0.01%
33,629
+1,132
+3% +$26.3K
MFL
2172
DELISTED
BLACKROCK MUNIHOLDINGS INVESTMENT QUALITY FUND
MFL
$779K ﹤0.01%
52,963
-1,756
-3% -$25.6K
AEIS icon
2173
Advanced Energy
AEIS
$13B
$777K ﹤0.01%
12,018
-2,558
-18% -$187K
ZOES
2174
DELISTED
Zoe's Kitchen, Inc.
ZOES
$775K ﹤0.01%
65,037
-1,257
-2% -$20.1K
PDN icon
2175
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$362M
$772K ﹤0.01%
24,727
-118
-0.5% -$3.6K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.